Article
gyrA and gyrB gene mutation in ciprofloxacin-resistant Mycobacterium massiliense clinical isolates from Southern Brazil.
Microbial drug resistance (Larchmont, N.Y.) - 1 Feb 2012
Monego Fernanda, Duarte Rafael Silva, Biondo Alexander Welker
Abstract excerpt
Fluoroquinolones (FQs) have been increasingly used for effective treatment of infections caused by rapidly growing mycobacteria, and resistance to this drug has been predominantly attributed to gyrA and gyrB mutations. Accordingly, this study investigated a total of 36 Mycobacterium massiliense clinical isolates for their susceptibility to ciprofloxacin and presence of gyrA and gyrB gene mutations. The minimal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
